Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Chu

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|July 3, 1998
Design of a new class of orally active fibrinogen receptor antagonistsS I Klein, B F Molino, M Czekaj, et al.
Journal of Cardiovascular Pharmacology|December 22, 1999
Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novel inhibitor of coagulation factor XaR J Leadley, S R Morgan, R Bentley, et al.
Journal of Medicinal Chemistry|March 4, 1998
Identification and initial structure-activity relationships of a novel class of nonpeptide inhibitors of blood coagulation factor XaS I Klein, M Czekaj, C J Gardner, et al.
Science Advances|September 8, 2018
Transparent arrays of bilayer-nanomesh microelectrodes for simultaneous electrophysiology and two-photon imaging in the brainYi Qiang, Pietro Artoni, Kyung Jin Seo, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XAY M Choi-Sledeski, M R Becker, D M Green, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitorsM R Becker, W R Ewing, R S Davis, et al.
Implementation Science : IS|August 11, 2020
Comparing a standard and tailored approach to scaling up an evidence-based intervention for antiretroviral therapy for people who inject drugs in Vietnam: study protocol for a cluster randomized hybrid type III trialMinh X B Nguyen, Anh V Chu, Byron J Powell, et al.
Journal of Medicinal Chemistry|September 10, 1999
Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor XaW R Ewing, M R Becker, V E Manetta, et al.
The Lancet. Global Health|November 15, 2025
Scaling an intervention for the engagement of people with HIV who inject drugs into care in Viet Nam: an implementation-effectiveness, cluster-randomised trialVivian F Go, Le M Giang, Huong T T Phan, et al.
Journal of Anxiety Disorders|February 11, 2023
The Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric and parent-proxy short forms for anxiety: Psychometric properties in the Kids FACE FEARS sampleGabrielle F Freitag, Hanan Salem, Kristina Conroy, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|July 3, 1998
Design of a new class of orally active fibrinogen receptor antagonistsS I Klein, B F Molino, M Czekaj, et al.
Journal of Cardiovascular Pharmacology|December 22, 1999
Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novel inhibitor of coagulation factor XaR J Leadley, S R Morgan, R Bentley, et al.
Journal of Medicinal Chemistry|March 4, 1998
Identification and initial structure-activity relationships of a novel class of nonpeptide inhibitors of blood coagulation factor XaS I Klein, M Czekaj, C J Gardner, et al.
Science Advances|September 8, 2018
Transparent arrays of bilayer-nanomesh microelectrodes for simultaneous electrophysiology and two-photon imaging in the brainYi Qiang, Pietro Artoni, Kyung Jin Seo, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XAY M Choi-Sledeski, M R Becker, D M Green, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitorsM R Becker, W R Ewing, R S Davis, et al.
Implementation Science : IS|August 11, 2020
Comparing a standard and tailored approach to scaling up an evidence-based intervention for antiretroviral therapy for people who inject drugs in Vietnam: study protocol for a cluster randomized hybrid type III trialMinh X B Nguyen, Anh V Chu, Byron J Powell, et al.
Journal of Medicinal Chemistry|September 10, 1999
Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor XaW R Ewing, M R Becker, V E Manetta, et al.
The Lancet. Global Health|November 15, 2025
Scaling an intervention for the engagement of people with HIV who inject drugs into care in Viet Nam: an implementation-effectiveness, cluster-randomised trialVivian F Go, Le M Giang, Huong T T Phan, et al.
Journal of Anxiety Disorders|February 11, 2023
The Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric and parent-proxy short forms for anxiety: Psychometric properties in the Kids FACE FEARS sampleGabrielle F Freitag, Hanan Salem, Kristina Conroy, et al.
Pageof 10